Reckitt Benckiser (RB) remained unbeaten in its third innings this year, recording strong growth in its Q3 15 trading update – 7% LFL sales growth (6% ytd), outperforming the previous quarter's results (5% and 3% LFL growth in Q2 15 and Q3 14, respectively) and comfortably beating consensus expectations. As expected, growth was driven by the core Health and Hygiene businesses (8% LFL growth in Q3, 7% ytd), which benefited from a strong innovation pipeline and strengthening consumer dema

27 Oct 2015
Strong and healthy on innovation dose

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong and healthy on innovation dose
Reckitt Benckiser Group plc (RKT:LON) | 5,406 -1946.2 (-0.7%) | Mkt Cap: 38,684m
- Published:
27 Oct 2015 -
Author:
Jyoti Prakash -
Pages:
3 -
Reckitt Benckiser (RB) remained unbeaten in its third innings this year, recording strong growth in its Q3 15 trading update – 7% LFL sales growth (6% ytd), outperforming the previous quarter's results (5% and 3% LFL growth in Q2 15 and Q3 14, respectively) and comfortably beating consensus expectations. As expected, growth was driven by the core Health and Hygiene businesses (8% LFL growth in Q3, 7% ytd), which benefited from a strong innovation pipeline and strengthening consumer dema